May 16, 2023
“At least seven large companies filed for Chapter 11 bankruptcy protection in less than 48 hours, a breakneck pace of restructurings that included once-hot digital-broadcaster Vice Media LLC and KKR & Co.-backed Envision Healthcare Corp. That’s the largest number of… Continue Reading…
December 14, 2020
“Vertex Pharmaceuticals (VRTX)… Overall, it appears that Wall Street agrees with Tenthoff. VRTX shares have a Strong Buy analyst consensus rating, based on 14 Buys and 4 Holds. The stock’s $287.50 average price target suggests it has room for 24% growth… Continue Reading…
October 5, 2020
“Kala Pharmaceuticals (KALA)… In general, other analysts echo Moussatos’ sentiment. 4 Buys and 1 Hold add up to a Strong Buy consensus rating. With an average price target of $20.80, the upside potential comes in at 173%… Revance Therapeutics (RVNC)…… Continue Reading…
October 2, 2020
“Kintara Therapeutics (KTRA)… Are other analysts in agreement? They are. Only Buy ratings, 3 to be exact, have been issued in the last three months. Therefore, the word on the Street is that KTRA is a Strong Buy. Given the… Continue Reading…
September 17, 2020
“Aquestive Therapeutics (AQST)… All in all, other analysts echo Moussatos’ sentiment. 3 Buys and no Holds or Sells add up to a Strong Buy consensus rating. With an average price target of $18.67, the upside potential comes in at 136%…… Continue Reading…
January 6, 2020
“What’s Happening With Aevi Genomic Medicine Inc Stock Today? Aevi Genomic Medicine Inc (GNMX) stock has gained 6.49% while the S&P 500 has fallen -0.61% as of 2:36 PM on Friday, Jan 3. GNMX is higher by $0.01 from the… Continue Reading…
September 26, 2019
“The average total cost of employer-provided health coverage passed $20,000 for a family plan this year, according to a new survey… Annual premiums rose 5% to hit $20,576 for an employer-provided family plan in 2019, according to the yearly poll… Continue Reading…
Recent Comments